NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email GTCR, the PE firm known for fintech and healthcare investments, plans to do more youth sports deals after closing its LiveBarn acquisition.Read More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026
